Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Jan 15, 2025
- Accession no.
- 0001447362-25-000014
- Filed
- Jan 15, 2025
- Trade date
- Jan 13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 21 non-derivative transactions. Open-market sales total $71.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 13, 2025 | Common Stock | SSaleDisposed | −556 | $27.51F2 | −$15,295.56 | 81,248 | Direct | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −285 | $27.51F2 | −$7,840.35 | 71,301 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −267 | $27.51F2 | −$7,345.17 | 60,780 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −85 | $27.51F2 | −$2,338.35 | 5,175 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −85 | $27.51F2 | −$2,338.35 | 5,169 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −85 | $27.51F2 | −$2,338.35 | 5,169 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −85 | $27.51F2 | −$2,338.35 | 5,169 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −399 | $28.65F9 | −$11,431.35 | 80,849 | Direct | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −204 | $28.65F9 | −$5,844.6 | 71,097 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −192 | $28.65F9 | −$5,500.8 | 60,588 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −60 | $28.65F9 | −$1,719 | 5,115 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −61 | $28.65F9 | −$1,747.65 | 5,108 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −60 | $28.65F9 | −$1,719 | 5,109 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −61 | $28.65F9 | −$1,747.65 | 5,108 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −31 | $29.48F10 | −$913.88 | 80,818 | Direct | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −16 | $29.48F10 | −$471.68 | 71,081 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −15 | $29.48F10 | −$442.2 | 60,573 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −5 | $29.48F10 | −$147.4 | 5,110 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −4 | $29.48F10 | −$117.92 | 5,104 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −5 | $29.48F10 | −$147.4 | 5,104 | Indirect | |
| Jan 13, 2025 | Common Stock | SSaleDisposed | −4 | $29.48F10 | −$117.92 | 5,104 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $27.15 to $28.00, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $28.17 to $29.05, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F10
This transaction was executed in multiple trades at the price of $29.48, inclusive. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.